| Eric D Popjes, MD | |
|
500 University Dr, Hershey, PA 17033-2360 | |
| (717) 531-8407 | |
| (717) 531-4077 |
| Full Name | Eric D Popjes |
|---|---|
| Gender | Male |
| Speciality | Advanced Heart Failure And Transplant Cardiology |
| Experience | 29 Years |
| Location | 500 University Dr, Hershey, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316905813 | NPI | - | NPPES |
| 001901988001 | Medicaid | PA |
| Facility Name | Location | Facility Type |
|---|---|---|
| Milton S Hershey Medical Center | Hershey, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The Milton S Hershey Medical Center Physicians Group | 3870405483 | 1400 |
News Archive
Being overweight or obese does not make asthma worse in patients with mild and moderate forms of the disease, according to a study by National Jewish Health researchers, although it may reduce the response to medications.
The National Institute of Health has awarded a $3.8 million research grant to Albert Einstein College of Medicine and Montefiore Health System for medical marijuana research, and Vireo Health of New York will be partners in the study.
Researchers at the University of Nebraska-Lincoln and Pennsylvania State University have found that a student's fitness level and iron status could be the difference between making an A or a B.
Xencor, Inc. announced today that the Company received a milestone payment from Boehringer Ingelheim. The payment was triggered by the regulatory submission for Phase 1 clinical trials of a novel monoclonal antibody that was optimized using one of Xencor's XmAb Fc (constant fragment) technology platforms under a technology license agreement entered in February 2007.
› Verified 8 days ago
| Entity Name | The Milton S Hershey Medical Center Physicians Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710951744 PECOS PAC ID: 3870405483 Enrollment ID: O20040225000741 |
News Archive
Being overweight or obese does not make asthma worse in patients with mild and moderate forms of the disease, according to a study by National Jewish Health researchers, although it may reduce the response to medications.
The National Institute of Health has awarded a $3.8 million research grant to Albert Einstein College of Medicine and Montefiore Health System for medical marijuana research, and Vireo Health of New York will be partners in the study.
Researchers at the University of Nebraska-Lincoln and Pennsylvania State University have found that a student's fitness level and iron status could be the difference between making an A or a B.
Xencor, Inc. announced today that the Company received a milestone payment from Boehringer Ingelheim. The payment was triggered by the regulatory submission for Phase 1 clinical trials of a novel monoclonal antibody that was optimized using one of Xencor's XmAb Fc (constant fragment) technology platforms under a technology license agreement entered in February 2007.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Eric D Popjes, MD Po Box 858, Mc A410, Hershey, PA 17033-0858 Ph: (800) 243-1455 | Eric D Popjes, MD 500 University Dr, Hershey, PA 17033-2360 Ph: (717) 531-8407 |
News Archive
Being overweight or obese does not make asthma worse in patients with mild and moderate forms of the disease, according to a study by National Jewish Health researchers, although it may reduce the response to medications.
The National Institute of Health has awarded a $3.8 million research grant to Albert Einstein College of Medicine and Montefiore Health System for medical marijuana research, and Vireo Health of New York will be partners in the study.
Researchers at the University of Nebraska-Lincoln and Pennsylvania State University have found that a student's fitness level and iron status could be the difference between making an A or a B.
Xencor, Inc. announced today that the Company received a milestone payment from Boehringer Ingelheim. The payment was triggered by the regulatory submission for Phase 1 clinical trials of a novel monoclonal antibody that was optimized using one of Xencor's XmAb Fc (constant fragment) technology platforms under a technology license agreement entered in February 2007.
› Verified 8 days ago
Nicole Swallow, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 500 University Dr, H088, Hershey, PA 17033 Phone: 717-531-1692 | |
Karen Louise Krok, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 500 University Dr, Hershey, PA 17033 Phone: 800-243-1455 Fax: 717-531-0061 | |
James O Ballard, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 500 University Dr, Hershey, PA 17033 Phone: 800-233-4082 | |
Poonam Na Bai, Internal Medicine Medicare: Medicare Enrolled Practice Location: 500 University Dr, Hershey, PA 17033 Phone: 717-531-6585 | |
Wilbert Hoffman Beachy Iv, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 500 University Dr, Hershey, PA 17033 Phone: 717-531-7300 | |
Samer Nabil Muallem, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 500 University Dr, Hershey, PA 17033 Phone: 800-243-1455 | |
Dr. Robert David Aronoff, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 500 University Dr, Hershey, PA 17033 Phone: 800-243-1455 |